Flow cytometry examination in U87-MG (human glioblastoma) and MDA-MB-231(human breast cancer) cell lines, which have moderate level and low level expression of c-MET, respectively, confirmed the specific binding capacity of rh-HGF to c-MET. The gene discussed is MET; the disease is breast cancer.